https://www.selleckchem.com/pr....oducts/eliglustat.ht
The density of forebrain dopamine transporters, a primary target of amphetamine, was also quantified in rats administered risperidone early in life and found to be reduced in the medial anterior, posterior, and ventral caudate nucleus. These results suggest that chronic risperidone treatment modifies later locomotor activity and sensitivity to the reinforcing effects of amphetamine, perhaps via a mechanism related to decreased forebrain dopamine transporter density.For over three-quarters of a century, organophosphorus (OP) insectici
Gefällt mir
Kommentar
Teilen
